chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Fatigue, Headache, Lymphadenopathy, Musculoskeletal stiffness
Clinical narrative: Itching; Burning; Redness; Headache; Nausea; Fever; Fatigue; Achiness; Soreness in that arm; Stiffness in that arm; Swelling of her neck and groin lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching), BURNING SENSATION (Burning), VACCINATION SITE ERYTHEMA (Redness), HEADACHE (Headache) and NAUSEA (Nausea) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching), BURNING SENSATION (Burning), VACCINATION SITE ERYTHEMA (Redness), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Achiness), PAIN IN EXTREMITY (Soreness in that arm), MUSCULOSKELETAL STIFFNESS (Stiffness in that arm) and LYMPHADENOPATHY (Swelling of her neck and groin lymph nodes). At the time of the report, VACCINATION SITE PRURITUS (Itching), BURNING SENSATION (Burning), VACCINATION SITE ERYTHEMA (Redness), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Achiness), PAIN IN EXTREMITY (Soreness in that arm), MUSCULOSKELETAL STIFFNESS (Stiffness in that arm) and LYMPHADENOPATHY (Swelling of her neck and groin lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain in extremity, Pyrexia, Vaccination site erythema
Clinical narrative: Itching; Burning; Redness; Headache; Nausea; Fever; Fatigue; Achiness; Soreness in that arm; Stiffness in that arm; Swelling of her neck and groin lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching), BURNING SENSATION (Burning), VACCINATION SITE ERYTHEMA (Redness), HEADACHE (Headache) and NAUSEA (Nausea) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching), BURNING SENSATION (Burning), VACCINATION SITE ERYTHEMA (Redness), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Achiness), PAIN IN EXTREMITY (Soreness in that arm), MUSCULOSKELETAL STIFFNESS (Stiffness in that arm) and LYMPHADENOPATHY (Swelling of her neck and groin lymph nodes). At the time of the report, VACCINATION SITE PRURITUS (Itching), BURNING SENSATION (Burning), VACCINATION SITE ERYTHEMA (Redness), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Achiness), PAIN IN EXTREMITY (Soreness in that arm), MUSCULOSKELETAL STIFFNESS (Stiffness in that arm) and LYMPHADENOPATHY (Swelling of her neck and groin lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Itching; Burning; Redness; Headache; Nausea; Fever; Fatigue; Achiness; Soreness in that arm; Stiffness in that arm; Swelling of her neck and groin lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching), BURNING SENSATION (Burning), VACCINATION SITE ERYTHEMA (Redness), HEADACHE (Headache) and NAUSEA (Nausea) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching), BURNING SENSATION (Burning), VACCINATION SITE ERYTHEMA (Redness), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Achiness), PAIN IN EXTREMITY (Soreness in that arm), MUSCULOSKELETAL STIFFNESS (Stiffness in that arm) and LYMPHADENOPATHY (Swelling of her neck and groin lymph nodes). At the time of the report, VACCINATION SITE PRURITUS (Itching), BURNING SENSATION (Burning), VACCINATION SITE ERYTHEMA (Redness), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Achiness), PAIN IN EXTREMITY (Soreness in that arm), MUSCULOSKELETAL STIFFNESS (Stiffness in that arm) and LYMPHADENOPATHY (Swelling of her neck and groin lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Hypertension
Clinical narrative: Headache; Diarrhea; Chills; Pressure went high; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), DIARRHOEA (Diarrhea), CHILLS (Chills) and HYPERTENSION (Pressure went high) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced HEADACHE (Headache), DIARRHOEA (Diarrhea), CHILLS (Chills) and HYPERTENSION (Pressure went high). At the time of the report, HEADACHE (Headache), DIARRHOEA (Diarrhea), CHILLS (Chills) and HYPERTENSION (Pressure went high) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site extravasation
Clinical narrative: fluid came out of injection site; A spontaneous report was received from a consumer concerning a male patient who received Modern's COVID-19 vaccine (mRNA-1273) and as soon the needle was removed from the injection site, fluid came out, not blood, pink fluid.  The patient's medical history was reported as cancer for 18years. Relevant concomitant medications reported were Finasteride 5 mcg and Tamsulosin 0.4mcg.    26-jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012M20A) for prophylaxis of COVID-19 infection, as soon the needle was removed from the injection site, fluid came out, not blood, pink fluid, so the provider cleaned that and after the fluid continues going out and provider cleaned again.  No Laboratory details provided.  No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.   At the time of this report, the outcome of the event injection site extravasation is Unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Tremor
Clinical narrative: itching everywhere; bad trembles and could not stop shaking; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (bad trembles and could not stop shaking) and PRURITUS (itching everywhere) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (experienced trembles and could not stop shaking).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced TREMOR (bad trembles and could not stop shaking). On an unknown date, the patient experienced PRURITUS (itching everywhere). At the time of the report, TREMOR (bad trembles and could not stop shaking) and PRURITUS (itching everywhere) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. The patient was treated with Benadryl (diphenhydramine) for the itching.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain, Pain in extremity, Pyrexia
Clinical narrative: Pain in the arm; Whole body hurts; Blurred vision; Chills; Fever 100.7; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm), PAIN (Whole body hurts), VISION BLURRED (Blurred vision), CHILLS (Chills) and PYREXIA (Fever 100.7) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L2OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm), PAIN (Whole body hurts), VISION BLURRED (Blurred vision), CHILLS (Chills), PYREXIA (Fever 100.7) and MYALGIA (Muscle aches). The patient was treated with IBUPROFEN at an unspecified dose and frequency and ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain in the arm), PAIN (Whole body hurts), VISION BLURRED (Blurred vision), CHILLS (Chills), PYREXIA (Fever 100.7) and MYALGIA (Muscle aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Pain in the arm; Whole body hurts; Blurred vision; Chills; Fever 100.7; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm), PAIN (Whole body hurts), VISION BLURRED (Blurred vision), CHILLS (Chills) and PYREXIA (Fever 100.7) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L2OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm), PAIN (Whole body hurts), VISION BLURRED (Blurred vision), CHILLS (Chills), PYREXIA (Fever 100.7) and MYALGIA (Muscle aches). The patient was treated with IBUPROFEN at an unspecified dose and frequency and ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain in the arm), PAIN (Whole body hurts), VISION BLURRED (Blurred vision), CHILLS (Chills), PYREXIA (Fever 100.7) and MYALGIA (Muscle aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site discolouration, Vaccination site erythema
Clinical narrative: brown faded circle at injection site; minor itching; 1.5in redness at site of injection; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE DISCOLOURATION (brown faded circle at injection site), PRURITUS (minor itching) and VACCINATION SITE ERYTHEMA (1.5in redness at site of injection) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer (patient is scheduled to have Breast cancer surgery next month.).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PRURITUS (minor itching) and VACCINATION SITE ERYTHEMA (1.5in redness at site of injection). On 18-Jan-2021, the patient experienced VACCINATION SITE DISCOLOURATION (brown faded circle at injection site). At the time of the report, VACCINATION SITE DISCOLOURATION (brown faded circle at injection site) and VACCINATION SITE ERYTHEMA (1.5in redness at site of injection) outcome was unknown and PRURITUS (minor itching) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash
Clinical narrative: red at the injection site; Rash at the site of shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at the site of shot) and VACCINATION SITE ERYTHEMA (red at the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031220A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer (her lymph nodes were taken out) and Lymph node excision. Concurrent medical conditions included Penicillin allergy, Drug allergy (Sulpher), Drug allergy (Codeine), Tremor and Acid reflux (esophageal). Concomitant products included ESOMEPRAZOLE for Acid reflux (esophageal), NADOLOL and TOPIRAMATE (TOPAMAX) for Tremor.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at the site of shot). On 18-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red at the injection site). The patient was treated with ACETAMINOPHEN at a dose of UNK dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site rash, at a dose of UNK dosage form. On 15-Jan-2021, VACCINATION SITE RASH (Rash at the site of shot) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (red at the injection site) had resolved. Not Provided          Reportedly, diphenhydramine and antihistaminic were rubbed on the site of shot and rash on the site of shot    Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Additional information received included: reporter details, Patient demographic details, Medical history, concomitant medication, Vaccination dates, lot# event start date, stop date, outcome and treatment details.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: itching at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039U20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itching at injection site). At the time of the report, VACCINATION SITE PRURITUS (itching at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: Red rash around the deltoid area with a bullseye appearance; Injection site was tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Red rash around the deltoid area with a bullseye appearance) and VACCINATION SITE PAIN (Injection site was tender) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012120A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE RASH (Red rash around the deltoid area with a bullseye appearance) and VACCINATION SITE PAIN (Injection site was tender). At the time of the report, VACCINATION SITE RASH (Red rash around the deltoid area with a bullseye appearance) and VACCINATION SITE PAIN (Injection site was tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: big red itchy circle about 2 inches; big red itchy circle about 2 inches; arm is still swollen; This spontaneous case was reported by a non-health professional and describes the occurrence of PRURITUS (big red itchy circle about 2 inches), ERYTHEMA (big red itchy circle about 2 inches) and PERIPHERAL SWELLING (arm is still swollen) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: Flu vaccine (she gets big red itchy circle from flu vaccine).    On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (big red itchy circle about 2 inches), ERYTHEMA (big red itchy circle about 2 inches) and PERIPHERAL SWELLING (arm is still swollen). At the time of the report, PRURITUS (big red itchy circle about 2 inches), ERYTHEMA (big red itchy circle about 2 inches) and PERIPHERAL SWELLING (arm is still swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Pallor, Pruritus
Clinical narrative: pale; itchiness; redness 4-4.5 inches in diameter around the injection site; swelling around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness), INJECTION SITE ERYTHEMA (redness 4-4.5 inches in diameter around the injection site), INJECTION SITE SWELLING (swelling around the injection site) and PALLOR (pale) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ANTIBIOTICS for Rosacea, LEVOTHYROXINE SODIUM (SYNTHROID), SPIRONOLACTONE and GABAPENTIN for an unknown indication.    On 02-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced PRURITUS (itchiness), INJECTION SITE ERYTHEMA (redness 4-4.5 inches in diameter around the injection site) and INJECTION SITE SWELLING (swelling around the injection site). On 18-Jan-2021, the patient experienced PALLOR (pale). On 15-Jan-2021, INJECTION SITE SWELLING (swelling around the injection site) had resolved. At the time of the report, PRURITUS (itchiness) and INJECTION SITE ERYTHEMA (redness 4-4.5 inches in diameter around the injection site) had not resolved and PALLOR (pale) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included hydrocortisone cream 3-4 times a day for a week
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea
Clinical narrative: Diarrhea; Stomach hurting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and ABDOMINAL PAIN (Stomach hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced DIARRHOEA (Diarrhea) and ABDOMINAL PAIN (Stomach hurting). At the time of the report, DIARRHOEA (Diarrhea) and ABDOMINAL PAIN (Stomach hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Fever; Chills; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and PAIN (Soreness) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN (Soreness). On 20-Jan-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PYREXIA (Fever), CHILLS (Chills) and PAIN (Soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Flushing, Influenza like illness
Clinical narrative: flush in face; flu like symptoms; mild sinus congestion; lightheaded; chills with rigors; fatigue; low grade fever 99.8 f; This spontaneous case was reported by a physician and describes the occurrence of FLUSHING (flush in face), INFLUENZA LIKE ILLNESS (flu like symptoms), SINUS CONGESTION (mild sinus congestion), DIZZINESS (lightheaded) and CHILLS (chills with rigors) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced FLUSHING (flush in face), INFLUENZA LIKE ILLNESS (flu like symptoms), SINUS CONGESTION (mild sinus congestion), DIZZINESS (lightheaded), CHILLS (chills with rigors), FATIGUE (fatigue) and PYREXIA (low grade fever 99.8 f). On 13-Jan-2021, FLUSHING (flush in face), INFLUENZA LIKE ILLNESS (flu like symptoms), SINUS CONGESTION (mild sinus congestion), DIZZINESS (lightheaded), CHILLS (chills with rigors), FATIGUE (fatigue) and PYREXIA (low grade fever 99.8 f) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. Treatment included Ibuprofen and Tylenol
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Sinus congestion
Clinical narrative: flush in face; flu like symptoms; mild sinus congestion; lightheaded; chills with rigors; fatigue; low grade fever 99.8 f; This spontaneous case was reported by a physician and describes the occurrence of FLUSHING (flush in face), INFLUENZA LIKE ILLNESS (flu like symptoms), SINUS CONGESTION (mild sinus congestion), DIZZINESS (lightheaded) and CHILLS (chills with rigors) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced FLUSHING (flush in face), INFLUENZA LIKE ILLNESS (flu like symptoms), SINUS CONGESTION (mild sinus congestion), DIZZINESS (lightheaded), CHILLS (chills with rigors), FATIGUE (fatigue) and PYREXIA (low grade fever 99.8 f). On 13-Jan-2021, FLUSHING (flush in face), INFLUENZA LIKE ILLNESS (flu like symptoms), SINUS CONGESTION (mild sinus congestion), DIZZINESS (lightheaded), CHILLS (chills with rigors), FATIGUE (fatigue) and PYREXIA (low grade fever 99.8 f) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. Treatment included Ibuprofen and Tylenol
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Inflammation, Peripheral swelling, Pruritus
Clinical narrative: Arm got all inflamed; Arm got swollen; Arm got all itchy; Arm got all red; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Arm got all inflamed), PERIPHERAL SWELLING (Arm got swollen), PRURITUS (Arm got all itchy) and ERYTHEMA (Arm got all red) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced INFLAMMATION (Arm got all inflamed), PERIPHERAL SWELLING (Arm got swollen), PRURITUS (Arm got all itchy) and ERYTHEMA (Arm got all red). At the time of the report, INFLAMMATION (Arm got all inflamed), PERIPHERAL SWELLING (Arm got swollen) and ERYTHEMA (Arm got all red) outcome was unknown and PRURITUS (Arm got all itchy) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy) in a 37-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concomitant products included OMEGA-3 FATTY ACIDS and pre natal vitamins for an unknown indication.    On 28-Jan-2021 at 9:05 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 28-Sep-2020 and the estimated date of delivery was 05-Jul-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  seventeenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnancy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: became a little tired after the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (became a little tired after the vaccination) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (became a little tired after the vaccination). At the time of the report, FATIGUE (became a little tired after the vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Non-significant follow-up appended. Reporter does not remember reporting an event for her brother-in-law
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Burning sensation, Chest pain, Feeling cold, Hyperhidrosis
Clinical narrative: Sweating; Burning in chest; Felt cold like vapor rub on arm; Feeling weak today; Pain in my arm; Burning in arms; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), CHEST PAIN (Burning in chest), FEELING COLD (Felt cold like vapor rub on arm), ASTHENIA (Feeling weak today) and PAIN IN EXTREMITY (Pain in my arm) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweating), CHEST PAIN (Burning in chest), FEELING COLD (Felt cold like vapor rub on arm), ASTHENIA (Feeling weak today), PAIN IN EXTREMITY (Pain in my arm) and BURNING SENSATION (Burning in arms). At the time of the report, HYPERHIDROSIS (Sweating), CHEST PAIN (Burning in chest), FEELING COLD (Felt cold like vapor rub on arm), ASTHENIA (Feeling weak today), PAIN IN EXTREMITY (Pain in my arm) and BURNING SENSATION (Burning in arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021:Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sweating; Burning in chest; Felt cold like vapor rub on arm; Feeling weak today; Pain in my arm; Burning in arms; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), CHEST PAIN (Burning in chest), FEELING COLD (Felt cold like vapor rub on arm), ASTHENIA (Feeling weak today) and PAIN IN EXTREMITY (Pain in my arm) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweating), CHEST PAIN (Burning in chest), FEELING COLD (Felt cold like vapor rub on arm), ASTHENIA (Feeling weak today), PAIN IN EXTREMITY (Pain in my arm) and BURNING SENSATION (Burning in arms). At the time of the report, HYPERHIDROSIS (Sweating), CHEST PAIN (Burning in chest), FEELING COLD (Felt cold like vapor rub on arm), ASTHENIA (Feeling weak today), PAIN IN EXTREMITY (Pain in my arm) and BURNING SENSATION (Burning in arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021:Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: red, itchy lesion on the injection site which progressed to become raised, very hard squarish; red, itchy lesion on the injection site which progressed to become raised, very hard squarish; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (red, itchy lesion on the injection site which progressed to become raised, very hard squarish) and VACCINATION SITE ERYTHEMA (red, itchy lesion on the injection site which progressed to become raised, very hard squarish) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (red, itchy lesion on the injection site which progressed to become raised, very hard squarish) and VACCINATION SITE ERYTHEMA (red, itchy lesion on the injection site which progressed to become raised, very hard squarish). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (red, itchy lesion on the injection site which progressed to become raised, very hard squarish) and VACCINATION SITE ERYTHEMA (red, itchy lesion on the injection site which progressed to become raised, very hard squarish) had resolved.            Concomitant medications were not provided.  Patient did not experience any adverse reaction after second dose of vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Event outcome and action taken updated.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site erythema, Injection site pain, Injection site pruritus, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (hotness at the vaccination site), INJECTION SITE ERYTHEMA (redness at the vaccination site), INJECTION SITE PRURITUS (itchiness at the vaccination site), MYALGIA (Muscle Pain) and ARTHRALGIA (joint pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included LEVOTHYROXINE, ATENOLOL, LORATADINE (CLARITINE) and SALBUTAMOL SULFATE (Pro Air INHALERIN) for an unknown indication.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2021, the patient experienced INJECTION SITE PAIN (hotness at the vaccination site), INJECTION SITE ERYTHEMA (redness at the vaccination site), INJECTION SITE PRURITUS (itchiness at the vaccination site), MYALGIA (Muscle Pain) and ARTHRALGIA (joint pain). At the time of the report, INJECTION SITE PAIN (hotness at the vaccination site), INJECTION SITE ERYTHEMA (redness at the vaccination site), INJECTION SITE PRURITUS (itchiness at the vaccination site), MYALGIA (Muscle Pain) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included topical cream, Advil to take 2 times daily, once in the morning and once at night until hotness is gone. Antibiotics
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Fatigue, Feeling abnormal, Hyperhidrosis
Clinical narrative: sweating; a little bruising at the injection site; feel foggy; heavy breathing; sore on the vaccination site; Tired; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), INJECTION SITE BRUISING (a little bruising at the injection site), FEELING ABNORMAL (feel foggy), DYSPNOEA (heavy breathing) and INJECTION SITE PAIN (sore on the vaccination site) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013O20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Artificial sweetener intolerance (Allergic to artificial sugar.(Sucrose)).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced HYPERHIDROSIS (sweating), INJECTION SITE BRUISING (a little bruising at the injection site), FEELING ABNORMAL (feel foggy), DYSPNOEA (heavy breathing), INJECTION SITE PAIN (sore on the vaccination site), FATIGUE (Tired) and CHILLS (chills). At the time of the report, HYPERHIDROSIS (sweating), INJECTION SITE BRUISING (a little bruising at the injection site), FEELING ABNORMAL (feel foggy), DYSPNOEA (heavy breathing), INJECTION SITE PAIN (sore on the vaccination site), FATIGUE (Tired) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site pain
Clinical narrative: sweating; a little bruising at the injection site; feel foggy; heavy breathing; sore on the vaccination site; Tired; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), INJECTION SITE BRUISING (a little bruising at the injection site), FEELING ABNORMAL (feel foggy), DYSPNOEA (heavy breathing) and INJECTION SITE PAIN (sore on the vaccination site) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013O20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Artificial sweetener intolerance (Allergic to artificial sugar.(Sucrose)).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced HYPERHIDROSIS (sweating), INJECTION SITE BRUISING (a little bruising at the injection site), FEELING ABNORMAL (feel foggy), DYSPNOEA (heavy breathing), INJECTION SITE PAIN (sore on the vaccination site), FATIGUE (Tired) and CHILLS (chills). At the time of the report, HYPERHIDROSIS (sweating), INJECTION SITE BRUISING (a little bruising at the injection site), FEELING ABNORMAL (feel foggy), DYSPNOEA (heavy breathing), INJECTION SITE PAIN (sore on the vaccination site), FATIGUE (Tired) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Prenatal screening test
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 37-year-old female patient (gravida 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included Miscarriage (ectopic) in May 2019, Alcohol use (very minimal) in May 2019 and Miscarriage (blighted ovum) in October 2019. Concurrent medical conditions included Drug hypersensitivity, Hypothyroidism since April 2010, Food allergy and Penicillin allergy. Concomitant products included LEVOTHYROXINE for Hypothyroidism, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 29-Jul-2020 and the estimated date of delivery was 05-May-2021. On 26-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-sixth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 26-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Aug-2020, Pregnancy test: positive (Positive) Positive. On 04-Nov-2020, Prenatal screening test: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Ultrasound was done at 5, 7, 10 and 20 weeks. Glucose screening was scheduled on 03-Feb-2021. Estimated date of conception was on 12-Aug-2020.   Treatment medications were not reported.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 37-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Vaccination site erythema; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE ERYTHEMA (red) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  The patient's past medical history included No adverse event. Concomitant products included CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 06-Jan-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE ERYTHEMA (red) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No treatment information provided.  Most recent FOLLOW-UP information incorporated above includes: On 18-Jan-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia
Clinical narrative: fever; body aches; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), PAIN (body aches), HEADACHE (headache) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical History).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), PAIN (body aches), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, PYREXIA (fever), PAIN (body aches), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea
Clinical narrative: Bad Diarrhea; His stomach feels a little queasy; This spontaneous case was reported by an other caregiver and describes the occurrence of DIARRHOEA (Bad Diarrhea) and NAUSEA (His stomach feels a little queasy) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced DIARRHOEA (Bad Diarrhea) and NAUSEA (His stomach feels a little queasy). At the time of the report, DIARRHOEA (Bad Diarrhea) and NAUSEA (His stomach feels a little queasy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.